Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
14.02 HKD | +0.14% |
|
-0.99% | -53.11% |
24/06 | ImmuneOnco Biopharmaceuticals Gets IND Approval for NMOSDs Drug Trial in China | MT |
03/06 | ImmuneOnco Biopharmaceuticals Gets China's Phase 3 Trial Approval for Leukemia Drug | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
671M | - | - | ||||
123B | ||||||
115B | ||||||
25.85B | - | |||||
20.9B | - | |||||
16.52B |